1. Modelling the impact of vaccination on COVID-19 in African countries.
- Author
-
Mathebula, Dephney, Amankwah, Abigail, Amouzouvi, Kossi, Assamagan, Kétévi Adiklè, Azote, Somiealo, Fajemisin, Jesutofunmi Ayo, Fankam Fankame, Jean Baptiste, Guga, Aluwani, Kamwela, Moses, Kanduza, Mulape Mutule, Mabote, Toivo Samuel, Macucule, Francisco Fenias, Muronga, Azwinndini, Njeri, Ann, Oluwole, Michael Olusegun, and Paulo, Cláudio Moisés
- Subjects
COVID-19 pandemic ,SARS-CoV-2 ,BREAKTHROUGH infections ,SOCIAL distancing ,VACCINE development - Abstract
The rapid development of vaccines to combat the spread of COVID-19, caused by the SARS-CoV-2 virus, is a great scientific achievement. Before the development of the COVID-19 vaccines, most studies capitalized on the available data that did not include pharmaceutical measures. Such studies focused on the impact of non-pharmaceutical measures such as social distancing, sanitation, use of face masks, and lockdowns to study the spread of COVID-19. In this study, we used the SIDARTHE-V model, an extension of the SIDARTHE model, which includes vaccination rollouts. We studied the impact of vaccination on the severity of the virus, specifically focusing on death rates, in African countries. The SIRDATHE-V model parameters were extracted by simultaneously fitting the COVID-19 cumulative data of deaths, recoveries, active cases, and full vaccinations reported by the governments of Ghana, Kenya, Mozambique, Nigeria, South Africa, Togo, and Zambia. Using South Africa as a case study, our analysis showed that the cumulative death rates declined drastically with the increased extent of vaccination drives. Whilst the infection rates sometimes increased with the arrival of new coronavirus variants, the death rates did not increase as they did before vaccination. Author summary: The onset of the COVID-19 pandemic prompted swift global responses. These included non-pharmaceutical control measures at the beginning of the pandemic such as social distancing, masks, and the later development of vaccines. In our first paper, we studied the evolution of the pandemic in the African continent by fitting the observed data with the SIRDATHE model in the first year (March 2020—March 2021) of the pandemic, before vaccination. We examined the impact of non-pharmaceutical control measures on COVID-19 transmission in the first year of the pandemic. As vaccination campaigns commenced, we extended our model to SIDARTHE-V model, which included the vaccination component. The SIRDATHE-V model assumes total immunity in the vaccinated population. However, our observations revealed breakthrough infections even amongst the vaccinated population. Therefore, in our application of the SIRDATHE-V model, we considered the fact that even the vaccinated could become infected. In this study, we investigated the impact of COVID-19 vaccination in Africa. We analysed COVID-19 data from seven African countries: Ghana, Kenya, Mozambique, Nigeria, South Africa, Togo, and Zambia over approximately two years, from March 2020 to March 2022. Considering variations in vaccination programs in each country, for example, the use of different vaccines and different starting dates, this study focused on the impact of vaccination on the death rates. Our findings showed a decline in cumulative death rates due to COVID-19 when vaccination drives were coupled with non-pharmaceutical control measures. We therefore conclude that in combating the spread of acute viral infections with dynamics similar to COVID-19, a comprehensive strategy involving both pharmaceutical (vaccination) and non-pharmaceutical (social measures) interventions is crucial. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF